arBtrage CAPITALIZING MARKETS checking… Sign in

Protalix BioTherapeutics, Inc.

PLX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.99
▼ -1.0% Today
as of Jun 7, 07:24 ET
Last 30 days -6.13% Apr 28 → Jun 05
$1.88 $1.95 $2.03 $2.10 $2.17 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.99
High
$2.02
Low
$1.98
Volume
$545,868
Avg Vol
$900,731
Mkt Cap
$169M
P/E (TTM)
7.96
Beta
52w High
$3.19
52w Low
$1.32
Div Yield
Shares Out

Overview

52-week range
$1.32
$3.19
36% of range
Avg surprise (last 2)
+1,069%
Avg reaction (last 2)
-19.7%
50% positive
Latest IV / EM
200%
EM ±27.6% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.06$0.01$0.08$0.15$0.22 Actual $0.21Actual $-0.04Actual $-0.06Actual $-0.03Actual $0.03Actual $-0.05Est $0.08Actual $0.03Actual $0.22Est $-0.01 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-4M$6M$16M$26M$35M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $0.22 $-0.01 +2,300% +540.0% +1.0% earnings
Tue Sep 30, 2025Sep 2025 $0.03 financials
Mon Jun 30, 2025Jun 2025 financials
Fri May 9, 2025Mar/2025 $-0.05 $0.08 -162.5% -40.5% earnings
Mon Sep 30, 2024Sep 2024 $0.03 financials
Sun Jun 30, 2024Jun 2024 $-0.03 financials
Sun Mar 31, 2024Mar 2024 $-0.06 financials
Sat Sep 30, 2023Sep 2023 $-0.04 financials
Fri Jun 30, 2023Jun 2023 $0.21 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$34M$18M$16M$10M$18M$13M
Cost of revenue$4M$8M$6M$8M$8M$9M
Gross profit
Operating income$21M$2M$1M$-4M$4M$-2M
Net income$18M$2M$164,000$-4M$3M$-2M
EPS (diluted)$0.22$0.03$-0.05$0.03$-0.03

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$41M$15M$14M$18M$19M$20M$27M$23M
Inventory$30M$26M$21M$21M$20M$21M$17M$21M
Total current assets$86M$67M$67M$65M$61M$60M$48M$77M
Total assets$102M$82M$82M$78M$74M$73M$62M$92M
Long-term debt
Total liabilities$35M$34M$29M$29M$29M$30M$29M$63M
Total equity$67M$48M$53M$50M$45M$43M$32M$29M

Implied volatility — last 90 days

194%197%199%202%204% Jun 07 — IV 200% · EM ±27.6%

Sector peers